As more rare disease therapies launch, their prices are rising
https://seekingalpha.com/news/4089415-more-rare-disease-therapies-launch-their-prices-rising?source=feed_sector_healthcare
Apr 16, 2024 - Rare disease therapies are extremely expensive, with some costing millions of dollars. They are getting even more pricey. Read more here.
0
C3.ai: Rare AI Value Stock That You Can Buy With Confidence
https://seekingalpha.com/article/4683917-c3ai-rare-ai-value-stock-that-you-can-buy-with-confidence?source=feed_all_articles
Apr 15, 2024 - C3.ai has been signing on more new deals, particularly with government clients, indicating a large market opportunity. Read why AI stock is a no-brainer Buy.
0
Ultragenyx reports serious adverse effects in rare disease therapy trial
https://seekingalpha.com/news/4089632-ultragenyx-reports-serious-adverse-effects-in-gene-therapy-trial?source=feed_sector_healthcare
Apr 15, 2024 - Shares of Ultragenyx Pharmaceutical (RARE) dropped 7% after serious adverse effects were reported in a gene therapy trial for Angelman syndrome.
0
REMX: This Rare Earth And Metals ETF Appears Poised For A Breakout
https://seekingalpha.com/article/4683379-remx-rare-earth-and-metals-etf-appears-poised-for-breakout?source=feed_tag_etf_portfolio_strategy
Apr 11, 2024 - VanEck Rare Earth/Strategic Metals ETF is a diversified investment option with potential for rebound amidst rising demand and prices. Read more on REMX here.
0
Rare Opportunity In The Columbia Seligman Premium Technology Growth CEF
https://seekingalpha.com/article/4681962-rare-opportunity-in-the-columbia-seligman-premium-technology-growth-cef-stk?source=feed_tag_etf_portfolio_strategy
Apr 03, 2024 - STK has historically been the premier option-write technology fund among CEFs, typically trading at a double-digit premium. Read why I'm bullish on the fund.
0
Rare Stock Picks In March 2024 - From 24 Discerning Analysts
https://seekingalpha.com/article/4681746-rare-stock-picks-in-march-2024-from-24-discerning-analysts?source=feed
Apr 03, 2024 - In our monthly Rare Stock Picks series, we're highlighting March 2024 investment picks. Click here for the list of March 2024 Buy recommendations.
0
MP Materials (MP) Receives $58.5M for Rare Earth Magnet Facility
https://www.zacks.com/stock/news/2249320/mp-materials-mp-receives-58-5m-for-rare-earth-magnet-facility?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2249320
Apr 02, 2024 - MP Materials (MP) expects to start the commercial production of finished magnets in late 2025 in its U.S. facility.
0
Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug
https://www.zacks.com/stock/news/2249187/solid-biosciences-sldb-falls-despite-fda-rare-tag-for-dmd-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249187
Apr 02, 2024 - Solid Biosciences' (SLDB) novel gene-therapy candidate, SGT-003, gets FDA's Rare Pediatric Disease Designation for the treatment of Duchenne muscular dystrophy.
0
AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod
https://www.zacks.com/stock/news/2249013/astrazeneca-s-azn-rare-blood-disorder-drug-gets-fda-nod?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249013
Apr 02, 2024 - FDA approves AstraZeneca's (AZN) Voydeya as an add-on to therapy to Ultomiris or Soliris for treating extravascular hemolysis in adult patients with paroxysmal nocturnal hemoglobinuria.
0
Rare Buying Opportunity: Big Dividends With Very Attractive Risk-Reward
https://seekingalpha.com/article/4681013-rare-buying-opportunity-big-dividends-attractive-risk-reward?source=feed
Mar 29, 2024 - Check here to learn why now is the perfect time for investors to explore discounted dividend stocks with great potential for high returns and limited risks.
0
Page 1>